Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases

Surgery

Volumn 146, Issue 1, 2009, Pages 52-59

  Neumann, Ulf P ^a   Thelen, Armin ^a   Röcken, Christoph ^a   Seehofer, Daniel ^a   Bahra, Marcus ^a   Riess, Hanno ^a   Jonas, Sven ^a   Schmeding, Maximilian ^a   Pratschke, Johann ^a   Bova, Roberta ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUCOVORIN; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 67349118442     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.02.004     Document Type: Article

References (36)

1. Folprecht G., Grothey A., Alberts S., Raab H.R., and Köhne C.H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16 (2005) 1311-1319
2. Fong Y., and Salo J. Surgical therapy of hepatic colorectal metastasis. Semin Oncol 26 (1999) 514-3
3. Jonas S., Thelen A., Benckert C., Spinelli A., Sammain S., Neumann U., et al. Extended resections of liver metastases from colorectal cancer. World J Surg 31 (2007) 511-521
4. Adams R.B., and Langer B. Resection margins for colorectal metastases to the liver: do they make a difference?. HPB Surg 9 (1996) 115-117
5. Scheele J., Stangl R., and Altendorf-Hofmann A. [Surgical interventions in liver metastases]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir (1990) 217-225
6. Scheele J., Stangl R., and Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
7. Adam R., Laurent A., Azoulay D., Castaing D., and Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232 (2000) 777-785
8. Adam R., Bismuth H., Castaing D., Waechter F., Navarro F., Abascal A., et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 225 (1997) 51-60 discussion 60-2
9. Jaeck D., Oussoultzoglou E., Rosso E., Greget M., Weber J.C., and Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 (2004) 1037-1049 discussion 1049-51
10. Adam R., Pascal G., Castaing D., Azoulay D., Delvart V., Paule B., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061 discussion 1061-4
11. Adam R., Huguet E., Azoulay D., Castaing D., Kunstlinger F., Levi F., et al. Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am 12 (2003) 211-220 xii
12. Giacchetti S., Itzhaki M., Gruia G., Adam R., Zidani R., Kunstlinger F., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10 (1999) 663-669
13. Fusai G., and Davidson B.R. Strategies to increase the resectability of liver metastases from colorectal cancer. Dig Surg 20 (2003) 481-496
14. Alberts S.R., Horvath W.L., Sternfeld W.C., Goldberg R.M., Mahoney M.R., Dakhil S.R., et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23 (2005) 9243-9249
15. Delaunoit T., Alberts S.R., Sargent D.J., Green E., Goldberg R.M., Krook J., et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 16 (2005) 425-429
16. Zelek L., Bugat R., Cherqui D., Ganem G., Valleur P., Guimbaud R., et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol 14 (2003) 1537-1542
17. Bismuth H., Adam R., Levi F., Farabos C., Waechter F., Castaing D., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224 (1996) 509-520 discussion 520-2
18. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318 discussion 318-21
19. Nordlinger B., Quilichini M.A., Parc R., Hannoun L., Delva E., and Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 205 (1987) 256-263
20. Nordlinger B., Guiguet M., Vaillant J.C., Balladur P., Boudjema K., Bachellier P., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77 (1996) 1254-1262
21. Johnson K., Bakhsh A., Young D., Martin Jr. T.E., and Arnold M. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 44 (2001) 354-357
22. In: Hamilton S.R., and Aaltonen L.A. (Eds). WHO classification of tumours. pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon, France
23. Abdalla E.K., and Vauthey J.N. Improved survival after resection of colorectal liver metastases. J Clin Oncol 24 (2006) 2679 author reply 2680-1
24. Choti M.A., Sitzmann J.V., Tiburi M.F., Sumetchotimetha W., Rangsin R., Schulick R.D., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
25. Fong Y., Cohen A.M., Fortner J.G., Enker W.E., Turnbull A.D., Coit D.G., et al. Liver resection for colorectal metastases. J Clin Oncol 15 (1997) 938-946
26. Scheele J., Rudroff C., and Altendorf-Hofmann A. Resection of colorectal liver metastases revisited. J Gastrointest Surg 1 (1997) 408-422
27. Clavien P.A., Selzner N., Morse M., Selzner M., and Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 131 (2002) 433-442
28. Jaeck D., Bachellier P., Nakano H., Oussoultzoglou E., Weber J.C., Wolf P., et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185 (2003) 221-229
29. Jaeck D., Bachellier P., Guiguet M., Feldo M., Vaillant J.C., Balladur P., et al. Survival benefit of repeat liver resection for recurrent colorectal metastases: 143 cases. Wiad Lek 50 Suppl 1 Pt 1 (1997) 102-104
30. Adam R. Developing strategies for liver metastases from colorectal cancer. Semin Oncol 34 2 Suppl 1 (2007) S7-11
31. Vauthey J.N., Pawlik T.M., Ribero D., Wu T.T., Zorzi D., Hoff P.M., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
32. Tanaka K., Adam R., Shimada H., Azoulay D., Levi F., and Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 (2003) 963-969
33. Allen P.J., Kemeny N., Jarnagin W., DeMatteo R., Blumgart L., and Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7 (2003) 109-115 discussion 116-7
34. Hewes J.C., Dighe S., Morris R.W., Hutchins R.R., Bhattacharya S., and Davidson B.R. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg 31 (2007) 353-364 discussion 355-6
35. Fernandez F.G., Drebin J.A., Linehan D.C., Dehdashti F., Siegel B.A., and Strasberg S.M. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-447 discussion 447-50
36. Adam R., Aloia T., Levi F., Wicherts D.A., de Haas R.J., Paule B., et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 25 (2007) 4593-4602